CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 120 filers reported holding CHEMOCENTRYX INC in Q2 2019. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $96,000 | +209.7% | 3,866 | +208.8% | 0.00% | – |
| Q1 2022 | $31,000 | -78.2% | 1,252 | -67.9% | 0.00% | -100.0% |
| Q4 2021 | $142,000 | +136.7% | 3,904 | +10.9% | 0.00% | – |
| Q3 2021 | $60,000 | +33.3% | 3,519 | +5.2% | 0.00% | – |
| Q2 2021 | $45,000 | -71.3% | 3,344 | +9.1% | 0.00% | -100.0% |
| Q1 2021 | $157,000 | -16.9% | 3,065 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $189,000 | +1250.0% | 3,050 | +1120.0% | 0.00% | – |
| Q3 2020 | $14,000 | -92.1% | 250 | -91.8% | 0.00% | -100.0% |
| Q2 2020 | $177,000 | +33.1% | 3,050 | -11.6% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | +392.6% | 3,450 | -13.8% | 0.00% | +200.0% |
| Q3 2019 | $27,000 | +42.1% | 4,000 | +100.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |